Bank Of New York Mellon Corp Avalo Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.0 - $10.45 $339,312 - $1.18 Million	-113,104 Reduced 70.07%	48,313 $24,000
Q4 2021 Feb 11, 2022	BUY	$19.68 - $28.68 $61,244 - $89,252	3,112 Added 1.97%	161,417 $274,000
Q3 2021 Nov 12, 2021	BUY	$26.16 - $40.68 $4.14 Million - $6.44 Million	158,305 New	158,305 $345,000

34.6K

Ticker AVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,414,100
Market Cap $91.1M
Description
Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.